Drug Discovery Consulting Services
Consulting Services for Drug Discovery
Pharmaron’s drug discovery consulting services give biotech and pharma access to our seasoned scientific experts. We partner closely with your team to define strategy, support project management, and translate strategy into practical experimental plans across disciplines. Through clear communication and proactive leadership, our drug discovery consultants help move your program toward milestone‑ready decisions.
Capabilities
How do Drug Discovery Teams Benefit from Consulting Services?
We support biotech, pharma, and university spin‑offs that need scientific leadership, decision‑making confidence, support to overcome roadblocks. Beyond advisory input, we turn strategy into real progress by leveraging Pharmaron’s in‑house contract research and manufacturing capabilities.
Examples of how drug discovery consultancy services advance programs:
- Gain early strategic clarity by refining target rationale, selecting the right modality, or defining an effective screening strategy.
- Get help interpreting complex data from biology, chemistry, DMPK, and translate it into into next-step experiments.
- Apply practical strategies to address scientific roadblocks, such as challenging SAR, ADME liabilities, or difficulty translating in vitro results to in vivo outcomes.
- Fill gaps in internal expertise with dedicated specialists who guide strategy and implement it into workflows.
Consulting Across Key Drug Discovery Disciplines
Medicinal Chemistry Consulting Services
Pharmaron’s medicinal chemistry consultants design and progress high‑quality compounds from idea to preclinical candidate.
Capabilities:
- Evaluate target biology and define hit‑finding strategies.
- Improve SAR (structure-activity relationships) to improve potency, selectivity, and developability.
- Coordinate design-make-synthesis-testing activities across departments to keep programs moving efficiently.
- Drive hit‑to‑lead and lead‑optimization phases.
- Provide scientific due diligence, patent landscape analysis, and IP strategy input.
CADD is a Core Component of Drug Discovery Consulting
Pharmaron’s computer-aided drug design consulting provides guidance on computational methods, helps clients choose the right design approaches and interprets complex in silico data to direct next experimental steps.
Capabilities:
- Recommend fit‑for‑purpose CADD strategies based on target biology and available structural data.
- Advise on virtual screening, hit prioritization, and design hypotheses through structure and ligand‑based modeling.
- Interpret computational outputs (docking, ADMET, AI/ML models) to guide medicinal chemistry direction.
- Integrate chemical, biological, structural, and ADME/PK data to support design decisions.
- Oversee computational workflows and coordinate iterative design cycles with wet‑lab teams.
DMPK Consulting
Pharmaron’s DMPK consultants provide strategic guidance to help clients understand how absorption, metabolism, distribution, and clearance impact compound progression. Our consultants advise on the experiments and modeling approaches that best de‑risk and advance a program from hit finding to first-in-human.
Capabilities:
- Troubleshoot PK/ADME challenges and propose targeted strategies.
- Assess developability and provide risk‑mitigation strategies.
- Design and oversee in vitro and in vivo DMPK experiments.
- Support translational PK/PD and biomarker planning.
- Coordinate integrated PK–formulation workflows for toxicology and clinical readiness.
Modeling and Simulation Expertise
Our PBPK (physiologically-based pharmacokinetic) modeling experts help select modeling approaches that fit each program, using them predict the behavior of the drug in the human body to inform dose strategies.
Capabilities:
- Support in vitro-in vivo translation and absorption modeling to inform formulation and dose planning.
- Model human PK, including complex mechanisms, and explore First‑in‑Human as well as later clinical phase scenarios.
- Evaluate biopharmaceutical properties, including food effects and alternative routes of administration.
- Predict potential drug-drug interactions and variability across patient population.
- Identify key ADME drivers and inform optimization through parameter sensitivity analysis
Biology Consulting Supporting Drug Discovery Programs
Our biology consultants ensure that the target biology is disease-relevant, experimentally tested, and translated into decisions that move the program forward.
Capabilities:
- Work with the client to shape target selection and validation plans.
- Design screening cascades that test potency as well as mechanism-of-action to help differentiate compounds early on.
- Integrate and interpret biological data across assays and model systems.
- Develop translational biology plans including in vitro–in vivo translation and PK/PD.
- Build biomarker and mechanistic readout strategies.
Would you like to schedule a free first consultation?
